Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
IL4R 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL4R, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL12B 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL12B, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL23A 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL23A, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL17RA 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL17RA, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
IL17A 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for IL17A, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
SELE 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for SELE, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
SELL 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for SELL, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
ICAM1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for ICAM1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
VCAM1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for VCAM1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
ITGA4 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for ITGA4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
S1PR1 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for S1PR1, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
CXCR4 2026 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
14 July 2026
A visual target evaluation report for CXCR4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.